Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Rituximab - Wikipedia
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Cells | Free Full-Text | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
Rituximab-related Severe Toxicity | SpringerLink
Internet Scientific Publications
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | SpringerLink
Rituximab in dermatology | Actas Dermo-Sifiliográficas
New Drugs for Rheumatoid Arthritis | NEJM
Main mechanisms of action of rituximab and ways to increase its... | Download Scientific Diagram
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Frontiers | Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
Biological Therapy for Rheumatoid Arthritis - ppt download
GPA & MPA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA)
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Rituximab (Rituxan) | American Journal of Neuroradiology
Role of biological agents in treatment of rheumatoid arthritis - ScienceDirect
Rheumatoid arthritis, other inflammatory arthritides and osteoarthritis - Medical Pharmacology and Therapeutics, 4e
The Risk of Hyperglycaemia with the use of Rituximab in Rheumatoid Arthritis. Results from a Meta-analysis of Randomised Clinica
Cells | Free Full-Text | Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
